Perioperative outcomes of interrupted anticoagulation in patients with non-valvular atrial fibrillation undergoing non-cardiac surgery

키워드

참고문헌 (27)

1. Lip GY, "Atrial fibrillation and stroke prevention", Lancet Neurol, 6, pp.981~993 (2007)
2. Wolf PA, "Impact of atrial fibrillation on mortality, stroke, and medical costs", Arch Intern Med, 158, pp.229~234 (1998)
3. Hughes M, "Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data", Thromb Haemost, 99, pp.295~304 (2008)
4. Go AS, "Prevalence of diagnosed atrial fibrillation in adults : national implications for rhythm management and stroke prevention : the AnTicoagulation and Risk Factors in Atrial Fibrillation(ATRIA)Study", JAMA, 285, pp.2370~2375 (2001)
5. Hylek EM, "Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation", N Engl J Med, 349, pp.1019~1026 (2003)
6. Rivera-Caravaca JM, "Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients", Thromb Haemost, 117, pp.1448~1454 (2017)
7. Heidbuchel H, "Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation : executive summary", Eur Heart J, 38, pp.2137~2149 (2017)
8. Wysokinski WE, "Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation", Mayo Clin Proc, 83, pp.639~645 (2008)
9. Doherty JU, "2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation : a report of the American College of Cardiology Clinical Expert Consensus Document Task Force", J Am Coll Cardiol, 69, pp.871~898 (2017)
10. Larsen TB, "Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation : propensity weighted nationwide cohort study", BMJ, 353, pp.i3189~ (2016)
11. Steffel J, "The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation", Eur Heart J, 39, pp.1330~1393 (2018)
12. Ruff CT, "Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation : a meta-analysis of randomised trials", Lancet, 383, pp.955~962 (2014)
13. Birman-Deych E, "Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation", Stroke, 37, pp.1070~1074 (2006)
14. Wallentin L, "Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation : an analysis of the RE-LY trial", Lancet, 376, pp.975~983 (2010)
15. Lopes RD, "Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation(ARISTOTLE)trial : design and rationale", Am Heart J, 159, pp.331~339 (2010)
16. Connolly SJ, "Newly identified events in the RE-LY trial", N Engl J Med, 363, pp.1875~1876 (2010)
17. Giugliano RP, "Edoxaban versus warfarin in patients with atrial fibrillation", N Engl J Med, 369, pp.2093~2104 (2013)
18. Granger CB, "Apixaban versus warfarin in patients with atrial fibrillation", N Engl J Med, 365, pp.981~992 (2011)
19. Patel MR, "Rivaroxaban versus warfarin in nonvalvular atrial fibrillation", N Engl J Med, 365, pp.883~891 (2011)
20. Connolly SJ, "Dabigatran versus warfarin in patients with atrial fibrillation", N Engl J Med, 361, pp.1139~1151 (2009)
21. Levy JH, "Discontinuation and management of direct-acting anticoagulants for emergency procedures", Am J Med, 129(11 Suppl), pp.S47~S53 (2016)
22. Kornej J, "Anticoagulation management in nonvalvular atrial fibrillation : current and future directions", Pol Arch Med Wewn, 123, pp.623~634 (2013)
23. Kearon C, "Management of anticoagulation before and after elective surgery", N Engl J Med, 336, pp.1506~1511 (1997)
24. Garcia DA, "Risk of thromboembolism with short-term interruption of warfarin therapy", Arch Intern Med, 168, pp.63~69 (2008)
25. Raval AN, "Management of patients on non-vitamin K antagonist oral anticoagulants in the acute care and periprocedural setting : a scientific statement from the American Heart Association", Circulation, 135, pp.e604~e633 (2017)
26. Douketis JD, "Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant", JAMA Intern Med, 179, pp.1469~1478 (2019)
27. Siegal D, "Periprocedural heparin bridging in patients receiving vitamin K antagonists : systematic review and meta-analysis of bleeding and thromboembolic rates", Circulation, 126, pp.1630~1639 (2012)

관련 논문AI추천